Purpose Primary debulking surgery (PDS) has historically been the standard treatment for advanced ovarian cancer. Recent data appear to support a paradigm shift toward neoadjuvant chemotherapy with interval debulking surgery (NACT-IDS). We hypothesized that stage IV ovarian cancer patients would likely ...
Using the comprehensive French national health insurance database, we emulated a target trial to explore the causal impacts of primary vs interval cytoreductive surgery on stage IV ovarian cancer prognosis (Surgery for Ovarian cancer FIGO 4: SOFI-4). The clone method with inverse probability of cen...
Among premenopausal women, ovarian suppression or ablation should be included in the treatment strategy. The CDK inhibitor Kisqali in combination with tamoxifen or an AI plus goserelin improve time of survival without cancer progression to 23.8 months compared to 13 months for tamoxifen or an AI plus...
Neoadjuvant chemotherapy for FIGO stage III or IV ovarian cancer: Survival benefit and prognostic factors. Int J Gynecol Cancer 2003;13:587–592. The survival benefit of neoadjuvant chemotherapy (NAC) was assessed in patients with FIGO stage III or IV ovarian cancer, and the prognostic value of...
To understand what having late-stage ovarian cancer means it may include asking your doctor questions like: What does advanced cancer mean for me? How long will I live? Which treatment options are available for me, and how could they help me?
The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol. 1992;47(2):203–9.PubMedView Article 8.Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst ...
(2015) Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized ... SC Institute 被引量: 11发表: 2013年 Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated? Paclitaxel/carboplatin...
kim's envita rev... when her breast cancer recurred, despite undergoing a mastectomy, radiation, and other standard conventional treatments, kim found herself gravitating toward alternative treatment... metastatic ovarian cancer treatment - kristy's env... delayed diagnosis and long wait times had ...
Primary chemotherapy and adjuvant tumor debulking in the management of advanced-stage epithelial ovarian cancer... T Le,W Faught,L Hopkins,... - 《International Journal of Gynecological Cancer》 被引量: 40发表: 2010年 Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a ...
Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients主要由Zhenhua Du、Xiaolin Ma编写,在2015年被Bangladesh Journal of Pharmacology收录,